Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$9.73 /

-1.93 (-16.55%)

, CGC

Canopy Growth

$26.65 /

-2.14 (-7.43%)

07:36
12/02/20
12/02
07:36
12/02/20
07:36

Cannabis reclassified by UN on WHO recommendation, Marijuana Business Daily says

The United Nations Commission on Narcotic Drugs on Wednesday accepted a World Health Organization recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs, according to Marijuana Business Daily. The eagerly awaited approval of Recommendation 5.1 had a slim majority in favor with 27 votes for, 1 abstention and 25 votes against, the publication notes. Publicly traded companies in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), Trulieve Cannabis (TCNNF) and Zynerba (ZYNE). Reference Link

ACB

Aurora Cannabis

$9.73 /

-1.93 (-16.55%)

CGC

Canopy Growth

$26.65 /

-2.14 (-7.43%)

IGC

India Globalization Capital

$1.80 /

-0.5 (-21.74%)

CANN

General Cannabis

$0.00 /

+ (+0.00%)

ZYNE

Zynerba

$4.47 /

-0.19 (-4.08%)

CRON

Cronos Group

$8.31 /

-0.51 (-5.78%)

TLRY

Tilray

$8.06 /

-0.97 (-10.74%)

CVSI

CV Sciences

$0.00 /

+ (+0.00%)

CNTTF

CannTrust Holdings

$0.00 /

+ (+0.00%)

APHA

Acquired by TLRY

$7.64 /

-0.715 (-8.56%)

TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

  • 08

    Dec

  • 17

    Dec

  • 11

    Nov

ACB Aurora Cannabis
$9.73 /

-1.93 (-16.55%)

11/17/20 GLJ Research
With $0 target, GLJ says short Aurora Cannabis on recent rally
11/16/20
Fly Intel: Top five analyst downgrades
11/16/20 Jefferies
Jefferies cuts Aurora Cannabis to Underperform after 'unjustified' re-rating
11/16/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
CGC Canopy Growth
$26.65 /

-2.14 (-7.43%)

11/30/20 BofA
Canopy Growth price target raised to C$42 from C$36 at BofA
11/16/20 Jefferies
Canopy Growth price target raised to $21.10 from $16 at Jefferies
11/11/20 CIBC
Canopy Growth price target raised to C$32 from C$25 at CIBC
11/10/20 Canaccord
Canopy Growth price target raised to C$25 from C$22 at Canaccord
IGC India Globalization Capital
$1.80 /

-0.5 (-21.74%)

08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
CANN General Cannabis
$0.00 /

+ (+0.00%)

ZYNE Zynerba
$4.47 /

-0.19 (-4.08%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
CRON Cronos Group
$8.31 /

-0.51 (-5.78%)

11/16/20 Jefferies
Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
06/24/20
Fly Intel: Top five analyst upgrades
TLRY Tilray
$8.06 /

-0.97 (-10.74%)

11/16/20 Jefferies
Jefferies downgrades Tilray to Underperform as international markets stall
11/16/20 Jefferies
Tilray downgraded to Underperform from Hold at Jefferies
11/11/20
Fly Intel: Top five analyst downgrades
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
CNTTF CannTrust Holdings
$0.00 /

+ (+0.00%)

APHA Acquired by TLRY
$7.64 /

-0.715 (-8.56%)

11/06/20 CIBC
Aphria price target raised to C$9 from C$8 at CIBC
10/16/20 CIBC
Aphria price target raised to C$8 from C$7.50 at CIBC
10/16/20 Cantor Fitzgerald
Aphria price target lowered to C$11.75 from C$15.50 at Cantor Fitzgerald
10/05/20 Cantor Fitzgerald
Aphria price target raised to C$15.50 from C$12.50 at Cantor Fitzgerald
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

11/18/20 Craig-Hallum
Trulieve Cannabis price target raised to $50 from $45 at Craig-Hallum
11/17/20 Alliance Global Partners
Trulieve Cannabis price target raised to C$50 from C$40 at Alliance Global
09/28/20 Craig-Hallum
Trulieve Cannabis price target raised to $45 from $40 at Craig-Hallum
09/25/20 Alliance Global Partners
Trulieve Cannabis initiated with a Buy at Alliance Global Partners

TODAY'S FREE FLY STORIES

Initiation
Iliad initiated with a Buy at Berenberg » 06:21
05/13/21
05/13
06:21
05/13/21
06:21
ILIAF

Iliad

$187.50 /

+ (+0.00%)

Berenberg analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILIAF Iliad
$187.50 /

+ (+0.00%)

04/21/21 Citi
Iliad initiated with a Buy at Citi
04/12/21 Kepler Cheuvreux
Iliad upgraded to Buy from Hold at Kepler Cheuvreux
02/09/21 HSBC
Iliad upgraded to Buy from Hold at HSBC
02/09/21 HSBC
Iliad upgraded to Buy from Hold at HSBC
Hot Stocks
Genetron announces strategic partnership with Siemens Healthineers » 06:21
05/13/21
05/13
06:21
05/13/21
06:21
GTH

Genetron

$18.85 /

+0.71 (+3.91%)

Genetron Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTH Genetron
$18.85 /

+0.71 (+3.91%)

GTH Genetron
$18.85 /

+0.71 (+3.91%)

09/30/20 Canaccord
Genetron China opportunity understated with current valuation, says Canaccord
08/03/20 Canaccord
Genetron outlook positive ahead of results, says Canaccord
07/14/20 BTIG
Genetron initiated with a Buy at BTIG
GTH Genetron
$18.85 /

+0.71 (+3.91%)

  • 19
    Jun
GTH Genetron
$18.85 /

+0.71 (+3.91%)

Earnings
Bioceres reports Q3 revenue $36.22M, consensus $27.42M » 06:20
05/13/21
05/13
06:20
05/13/21
06:20
BIOX

Bioceres

$14.79 /

-0.56 (-3.65%)

Reports Q3 comparable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIOX Bioceres
$14.79 /

-0.56 (-3.65%)

BIOX Bioceres
$14.79 /

-0.56 (-3.65%)

04/08/21 Lake Street
Bioceres price target raised to $20 from $15 at Lake Street
03/15/21 Lake Street
Bioceres initiated with a Buy at Lake Street
BIOX Bioceres
$14.79 /

-0.56 (-3.65%)

BIOX Bioceres
$14.79 /

-0.56 (-3.65%)

Upgrade
Points International upgraded to Outperform from Sector Perform at RBC Capital » 06:18
05/13/21
05/13
06:18
05/13/21
06:18
PCOM

Points International

$15.93 /

-0.07 (-0.44%)

RBC Capital analyst Drew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCOM Points International
$15.93 /

-0.07 (-0.44%)

PCOM Points International
$15.93 /

-0.07 (-0.44%)

07/20/20 Barrington
Points International initiated with an Outperform at Barrington
Upgrade
SKF AB upgraded to Neutral from Underweight at JPMorgan » 06:18
05/13/21
05/13
06:18
05/13/21
06:18
SKFRY

SKF AB

$26.47 /

-0.55 (-2.04%)

JPMorgan analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKFRY SKF AB
$26.47 /

-0.55 (-2.04%)

04/26/21 Citi
SKF AB price target lowered to SEK 245 from SEK 258 at Citi
04/23/21 RBC Capital
SKF AB price target raised to SEK 300 from SEK 280 at RBC Capital
04/23/21 Morgan Stanley
SKF AB price target raised to SEK 234 from SEK 192 at Morgan Stanley
04/23/21 Credit Suisse
SKF AB price target raised to SEK 170 from SEK 155 at Credit Suisse
Initiation
International Game reinstated with an Outperform at Credit Suisse » 06:16
05/13/21
05/13
06:16
05/13/21
06:16
IGT

International Game

$20.07 /

-0.32 (-1.57%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IGT International Game
$20.07 /

-0.32 (-1.57%)

IGT International Game
$20.07 /

-0.32 (-1.57%)

05/12/21 Deutsche Bank
International Game price target raised to $32 from $28 at Deutsche Bank
03/26/21 Deutsche Bank
International Game online unit worth $8 per share on own, says Deutsche Bank
03/03/21 Macquarie
International Game price target raised to $25 from $22 at Macquarie
01/19/21 Jefferies
International Game upgraded to Buy from Hold at Jefferies
IGT International Game
$20.07 /

-0.32 (-1.57%)

IGT International Game
$20.07 /

-0.32 (-1.57%)

IGT International Game
$20.07 /

-0.32 (-1.57%)

Recommendations
Myovant Sciences price target lowered to $24 from $30 at Citi » 06:14
05/13/21
05/13
06:14
05/13/21
06:14
MYOV

Myovant Sciences

$20.66 /

+0.82 (+4.13%)

Citi analyst Mohit Bansal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MYOV Myovant Sciences
$20.66 /

+0.82 (+4.13%)

MYOV Myovant Sciences
$20.66 /

+0.82 (+4.13%)

05/03/21 JPMorgan
Myovant Sciences price target lowered to $32 from $38 at JPMorgan
01/08/21 SVB Leerink
Myovant Sciences downgraded to Market Perform from Outperform at SVB Leerink
01/06/21 Goldman Sachs
Myovant Sciences downgraded to Neutral from Buy at Goldman Sachs
12/29/20 Citi
Citi boosts Myovant target to $30 on 'smart deal' with Pfizer
MYOV Myovant Sciences
$20.66 /

+0.82 (+4.13%)

MYOV Myovant Sciences
$20.66 /

+0.82 (+4.13%)

Hot Stocks
CleanSpark acquires 2,400 additional S19-Pro Bitcoin mining rigs » 06:14
05/13/21
05/13
06:14
05/13/21
06:14
CLSK

CleanSpark

$14.70 /

-1.02 (-6.49%)

CleanSpark announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
02/16/21 H.C. Wainwright
CleanSpark price target raised to $50 from $24 at H.C. Wainwright
12/11/20 H.C. Wainwright
CleanSpark price target raised to $24 from $18 at H.C. Wainwright
CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

  • 16
    Mar
  • 07
    Oct
CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

CLSK CleanSpark
$14.70 /

-1.02 (-6.49%)

Periodicals
CDC confirms 28 cases of rare disorder linked to J&J vaccine, NY Times reports » 06:13
05/13/21
05/13
06:13
05/13/21
06:13
JNJ

Johnson & Johnson

$168.21 /

-0.62 (-0.37%)

The Centers for Disease…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/26/21 B. Riley
B. Riley reiterates Buy on Novavax, Sell on Arcturus amid vaccine developments
04/19/21 Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

JNJ Johnson & Johnson
$168.21 /

-0.62 (-0.37%)

Recommendations
Dynatrace price target raised to $67 from $63 at Citi » 06:13
05/13/21
05/13
06:13
05/13/21
06:13
DT

Dynatrace

$44.92 /

-0.515 (-1.13%)

Citi analyst Tyler Radke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DT Dynatrace
$44.92 /

-0.515 (-1.13%)

DT Dynatrace
$44.92 /

-0.515 (-1.13%)

03/22/21 Goldman Sachs
Dynatrace initiated with a Buy at Goldman Sachs
03/03/21 Citi
Dynatrace assumed with a Buy at Citi
02/04/21
Dynatrace price target raised to $50 from $40 at Loop Capital
02/04/21
Dynatrace price target raised to $65 from $50 at DA Davidson
DT Dynatrace
$44.92 /

-0.515 (-1.13%)

  • 09
    Dec
  • 03
    Aug
  • 03
    Jun
DT Dynatrace
$44.92 /

-0.515 (-1.13%)

Earnings
National Vision raises FY21 adjusted EPS view to $1.07-$1.12 from 88c-93c » 06:12
05/13/21
05/13
06:12
05/13/21
06:12
EYE

National Vision

$46.89 /

-3.11 (-6.22%)

Consensus for FY21 EPS is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYE National Vision
$46.89 /

-3.11 (-6.22%)

EYE National Vision
$46.89 /

-3.11 (-6.22%)

03/04/21 Citi
National Vision price target raised to $57 from $52 at Citi
03/03/21 Wells Fargo
National Vision price target raised to $55 at Wells Fargo after Q4 results
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital on valuation
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital
EYE National Vision
$46.89 /

-3.11 (-6.22%)

  • 04
    Mar
EYE National Vision
$46.89 /

-3.11 (-6.22%)

Recommendations
1Life Healthcare price target lowered to $55 from $61 at Citi » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
ONEM

1Life Healthcare

$38.27 /

-0.49 (-1.26%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

05:03 Today Piper Sandler
1Life Healthcare earnings selloff a buying opportunity, says Piper Sandler
05/03/21 Jefferies
Jefferies confident in path to 'much larger' 1Life Healthcare, starts at Buy
05/03/21 Jefferies
1Life Healthcare initiated with a Buy at Jefferies
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

Hot Stocks
KBR awarded $51.2M NOAA contract » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
KBR

KBR

$40.33 /

-0.36 (-0.88%)

KBR won a new $51.2M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$40.33 /

-0.36 (-0.88%)

KBR KBR
$40.33 /

-0.36 (-0.88%)

04/21/21 Citi
KBR price target raised to $45 from $38 at Citi
03/29/21 DA Davidson
KBR price target raised to $40 from $30 at DA Davidson
03/26/21 Truist
KBR price target raised to $44 from $40 at Truist
02/23/21 Citi
KBR price target raised to $38 from $37 at Citi
KBR KBR
$40.33 /

-0.36 (-0.88%)

Upgrade
GrafTech upgraded to Outperform at RBC Capital on improving steel market » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
EAF

GrafTech

$12.62 /

-0.17 (-1.33%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

EAF GrafTech
$12.62 /

-0.17 (-1.33%)

05:29 Today RBC Capital
GrafTech upgraded to Outperform from Sector Perform at RBC Capital
02/08/21 Citi
Citi upgrades GrafTech to Buy, doubles price target to $15
02/08/21 Citi
GrafTech upgraded to Buy from Neutral at Citi
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

  • 02
    Mar
  • 15
    Jan
  • 15
    Dec
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

Earnings
Natural Gas Services reports Q1 EPS (3c), consensus (8c) » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
NGS

Natural Gas Services

$9.62 /

-0.08 (-0.82%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

08/20/20 Maxim
Natural Gas Services price target raised to $12 from $7 at Maxim
NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

Periodicals
Apple engineer out after employees call for investigation, The Verge reports » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
AAPL

Apple

$122.82 /

-3.02 (-2.40%)

Top Apple engineer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

05/11/21 Evercore ISI
Chinese data points to smartphone market slowdown in April, says Evercore ISI
05/11/21 Bernstein
Mix shift to Pro/Pro Max behind Apple iPhone ASPs strength, says Bernstein
05/07/21 Northland
II-VI upgraded to Outperform from Market Perform at Northland
05/05/21 Bernstein
Bernstein sees modest financial consequence to Apple even with adverse rulings
AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

Hot Stocks
Becton Dickinson announces self-collection claim for HPV screening CE marked » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
BDX

Becton Dickinson

$241.63 /

+0.49 (+0.20%)

Becton Dickinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

04/05/21 Argus
Weaker demand for Covid testing solutions to weigh on BD, says Argus
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/12/21 Wells Fargo
Wells Fargo sees only 'small chance' of positive FDA panel for Becton
02/05/21 Citi
Becton Dickinson price target raised to $280 from $273 at Citi
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

  • 21
    May
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

Earnings
National Vision reports Q1 adjusted EPS 48c, consensus 31c » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
EYE

National Vision

$46.89 /

-3.11 (-6.22%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYE National Vision
$46.89 /

-3.11 (-6.22%)

EYE National Vision
$46.89 /

-3.11 (-6.22%)

03/04/21 Citi
National Vision price target raised to $57 from $52 at Citi
03/03/21 Wells Fargo
National Vision price target raised to $55 at Wells Fargo after Q4 results
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital on valuation
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital
EYE National Vision
$46.89 /

-3.11 (-6.22%)

  • 04
    Mar
EYE National Vision
$46.89 /

-3.11 (-6.22%)

Initiation
HCA Healthcare resumed with a Neutral at Citi » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
HCA

HCA Healthcare

$204.27 /

-2.23 (-1.08%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

04/26/21
Fly Intel: Top five analyst downgrades
04/26/21 BMO Capital
HCA Healthcare price target raised to $222 from $200 at BMO Capital
04/26/21 Citi
HCA Healthcare downgraded to Neutral from Buy at Citi
04/23/21 Raymond James
HCA Healthcare price target raised to $225 from $190 at Raymond James
HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

Earnings
Fennec reports Q1 EPS (18c), consensus (13c » 06:09
05/13/21
05/13
06:09
05/13/21
06:09
FENC

Fennec

$6.01 /

-0.05 (-0.83%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FENC Fennec
$6.01 /

-0.05 (-0.83%)

04/21/21 Craig-Hallum
Fennec initiated with a Buy at Craig-Hallum
04/19/21 Maxim
Fennec initiated with a Buy at Maxim
04/19/21 Maxim
Fennec initiated with a Buy at Maxim
08/12/20 Wedbush
Fennec price target lowered to $11 from $18 at Wedbush
FENC Fennec
$6.01 /

-0.05 (-0.83%)

Recommendations
NIO notes chip shortage remains key production constraint, says Citi » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
NIO

NIO

$33.67 /

-1.195 (-3.43%)

Citi analyst Jeff Chung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Morgan Stanley
NIO on track for Q2 target after April deliveries, says Morgan Stanley
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
NIO NIO
$33.67 /

-1.195 (-3.43%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

Earnings
Haemonetics sees FY22 adjusted EPS $2.60-$3.00, consensus $3.48 » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
HAE

Haemonetics

$59.85 /

+0.225 (+0.38%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

04/20/21 Raymond James
CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
04/20/21 Jefferies
Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
04/20/21 Morgan Stanley
Haemonetics downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/21 Needham
Haemonetics price target lowered to $108 from $158 at Needham
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

Upgrade
Albemarle upgraded to Sector Perform from Underperform at RBC Capital » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
ALB

Albemarle

$154.71 /

-5.575 (-3.48%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

05:29 Today RBC Capital
Albemarle upgraded to Sector Perform from Underperform at RBC Capital
05/12/21 Wells Fargo
Albemarle price target raised to $175 from $162 at Wells Fargo
05/10/21 Citi
Albemarle price target raised to $191 from $174 at Citi
05/07/21
Fly Intel: Top five analyst upgrades
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

  • 04
    Feb
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

Earnings
MultiPlan sees 2021 revenue $1.04B-$1.10B, consensus $1.03B » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
MPLN

MultiPlan

$6.15 /

-0.655 (-9.63%)

Sees 2021 Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
03/19/21 Barclays
MultiPlan initiated with an Equal Weight at Barclays
03/11/21 Citi
Citi 'scratching our heads' over MultiPlan not issuing 2021 guidance
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

Hot Stocks
Second Sight announces year three NIH funding of Orion study » 06:07
05/13/21
05/13
06:07
05/13/21
06:07
EYES

Second Sight

$6.31 /

+1.35 (+27.22%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.